A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*-论文-万方医学网

A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*

导出原文传递

翻译打印收藏纠错

作者： Lonze, Bonnie E. ^[1] ; Spiegler, Peter ^[2] ; Wesson, Russell N. ^[3] ; Alachkar, Nada ^[4] ; Petkova, Eva ^[5] ; Weldon, Elaina P. ^[6] ; Dieter, Rebecca A. ; Li, Yi ; Quinn, Max ; Mattoo, Aprajita ; Soomro, Irfana ; Cohen, Steven M. ; Leung, Sherry ; Deterville, Cecilia L. ; Landrum, B. Mark ; Ali, Muhammad Imran ; Cohen, David J. ; Singer, Andrew L. ; Sen, Ayan ; Chong, Edward ; Hochman, Judith S. ; Troxel, Andrea B. ; Montgomery, Robert A.

作者单位： NYU Langone Medical Center,NYU Langone Hlth ^[1] Johns Hopkins Med ^[2] New York United Hlth Serv Hosp ^[3] Med Ctr,Columbia Univ ^[4] Mayo Clin Arizona ^[5] Vitaeris Inc ^[6]

关键词 acute respiratory distress syndrome clazakizumab COVID-19 cytokine inhibition hyperinflammation

发布时间 2022-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除